Czech Republic: Recommended vaccinations
  General recommendation
  Recommendation for specific groups only
  Catch-up (e.g. if previous doses missed)
 
Vaccination not funded by the National Health system
 
Mandatory vaccination
BirthWeeksMonthsYears
62345611121315185-610-11131415182649505960646566≥ 67
Coronavirus disease (COVID-19)
COVID-193
tuberculosis
BCG4
rotavirus infection
ROTA5
ROTA5
ROTA5
diphtheria
D6
D
D
d
d
tetanus
TT6
TT
TT
TT
TT
TT7
TT
pertussis
acP6
acP
acP
acp
acp
acp8
acp
poliomyelitis
IPV6
IPV
IPV
IPV
Haemophilus influenzae type b infection1
Hib6
Hib
Hib
Hib
hepatitis B
HepB9
HepB6
HepB
HepB
HepB10
pneumococcal disease
PCV11
PCV12
PCV13
PCV13+PPSV2314
PCV13+PPSV2315
meningococcal disease
MenB16
MenB17
MCV4/MenB18
MCV4/MenB16
measles2
MEAS
MEAS
MEAS19
mumps
MUMPS
MUMPS
rubella
RUBE
RUBE
varicella
VAR
VAR
VAR
human papillomavirus infection
HPV (F/M)20
HPV (F/M)
influenza
IIV421
IIV422
herpes zoster
ZOS
ZOS23
hepatitis A
HepA24
tick-borne encephalitis
TBE25
TBE26
rabies
Rab-I27

Version:


Footnotes:

  1. For specific risk groups vaccination is covered by the health insurance.
  2. Vaccination of one dose against measles for those aged 18 years and above who are newly admitted to work on an infectious or dermatovenerological ward (mandatory vaccination)
  3. https://koronavirus.mzcr.cz/ockovani-proti-covid-19/
  4. Administered from 4th day until 6 weeks after birth. Given only to babies in at-risk groups.
  5. Recommended only. Vaccination not funded by the National Health system or health insurance.
  6. The first dose of hexavalent vaccine is given from the end of the 2nd month of life, at intervals of two months between the first and the second dose, and the third dose given between the eleventh and thirteenth months of the child's age
  7. Booster dose for person between 25th and 26th years of age; next booster dose every 10 - 15 years
  8. Pertussis vaccination is recommended for pregnant women from the 27th gestational week. Vaccination is recommended at every pregnancy.
  9. Babies born to HBsAg-positive mothers will be given a first dose within 24 hours after birth by law
  10. 3 doses. if susceptible and no history of vaccination. mandatory for specific at risk groups
  11. PCV13. First dose. Recommendation only, the vaccination is covered by the health insurance
  12. Recommendation only, the vaccination is covered by the health insurance. 2nd dose.
  13. 3rd dose.
  14. Any PCV or PPSV23. Vaccination is especially recommended for people with chronic lung disease (includes moderate and severe bronchial asthma), with long-term medical treatment; persons with heart disease and/or large vessels with long-term systemic medical treatment, such as hypertension; people with chronic kidney and liver disease; patients with diabetes mellitus; patients with an immune disorder system (eg patients with immunosuppressive treatment (steroids, HIV infections, etc.) and asplenia / hyposplenia; patients with anticancer treatment; patients before / after solid organ and / or bone marrow transplantation; people with severe obesity (BMI over 40 kg / m2) and persons over 65 years of age.
  15. https://www.vakcinace.eu/data/files/downloads/ockovaci_kalendar_dospsdatem.pdf
  16. 1. Vaccination with MenB vaccine and MCV4 vaccine is covered by health insurance for persons of all ages with immune disorders since January 2018. 2. Vaccination is covered by health insurance for small infants since May 2020 for MenB vaccine if vaccination is started before the age of six months and for MCV4 vaccine if vaccination is given as a single dose in the second year of life. 3. In September 2021, the inclusion of vaccinations with MCV4 and MenB vaccine for adolescents in addition to small infants as covered by health insurance was newly approved; from January 2022, an amendment to the law is to enter into force and vaccinations are to be paid for: a. MenB vaccine if it is started before the age of 12 months or from the completion of the fourteenth to the completion of the fifteenth year of the age; b. MCV4 vaccine if it is made in a single dose from the completion of the first to the completion of the second year of age or from the completion of the fourteenth to the completion of the fifteenth year of the age. Recommendation (Czech, English) http://www.szu.cz/ockovani-proti-meningokokovym-onemocnenim
  17. 2nd dose.
  18. 3rd dose of MenB. 1. Vaccination with MenB vaccine and MCV4 vaccine is covered by health insurance for persons of all ages with immune disorders since January 2018. 2. Vaccination is covered by health insurance for small infants since May 2020 for MenB vaccine if vaccination is started before the age of six months and for MCV4 vaccine if vaccination is given as a single dose in the second year of life. 3. In September 2021, the inclusion of vaccinations with MCV4 and MenB vaccine for adolescents in addition to small infants as covered by health insurance was newly approved; from January 2022, an amendment to the law is to enter into force and vaccinations are to be paid for: a. MenB vaccine if it is started before the age of 12 months or from the completion of the fourteenth to the completion of the fifteenth year of the age; b. MCV4 vaccine if it is made in a single dose from the completion of the first to the completion of the second year of age or from the completion of the fourteenth to the completion of the fifteenth year of the age. Recommendation (Czech, English) http://www.szu.cz/ockovani-proti-meningokokovym-onemocnenim
  19. catch-up for are newly admitted to work on an infectious or dermatovenerological ward
  20. Gender-neutral (boys and girls) vaccination recommended since September 2019. Vaccination is covered by health insurance for all 13-14-year old. 2 and 4 valent vaccine.
  21. For at-risk groups of any age. Recommended only. The vaccination is covered by the health insurance. In addition, there is a general recommendation for whole population. This vaccination is not covered by the health insurance.
  22. Recommended only. The vaccination is covered by the health insurance.
  23. Vaccination is recommended to start as soon as possible
  24. General recommendation for all population. 2 doses, if susceptible and no history of vaccination. Mandatory for specific at-risk groups. Vaccination not funded by the National Health system except at-risk groups.
  25. 3 doses, re-vaccination every 5 years. Recommended only. Vaccination not funded by the National Health system.
  26. 3 doses, re-vaccination every 3 years. Recommended only. Vaccination not funded by the National Health system.
  27. 5 doses post-exposure, 3 doses pre-exposure


More information available at:
http://www.szu.cz/tema/vakciny/ockovaci-kalendar-v-cr?highlightWords=O%C4%8Dkovac%C3%AD+kalend%C3%A1%C5%99+%C4%8CR http://www.szu.cz/uploads/Epidemiologie/2014_CR_ockovaci_kalendar.pdf http://www.mzcr.cz/Verejne/obsah/stanoviska-a-doporuceni_1985_5.html http://www.vakcinace.eu/ockovani-v-cr


_______________________________________________________________________


HISTORICAL CHANGES:
1946: Diphteria vaccination introduced into the national childhood vaccination schedule
1952: Tetanus vaccination administered to children in communities
1953: TB vaccination introduced into the national childhood vaccination schedule
1956: Tetanus vaccination introduced into the national childhood vaccination schedule
1958: WCP vaccination introduced into the national childhood vaccination schedule
1960-1969: Oral polio vaccination present in the national childhood vaccination schedule
1969: Measles vaccination for babies at 12 months of age introduced into the national childhood vaccination schedule
1982: Measles – two dose vaccination regime administered to children at 15 months of age and 6-10 months after receiving the first dose
1982: Rubella vaccination for 12 year old girls introduced into the national childhood vaccination schedule
1986: Rubella vaccination for children at 2 years of age introduced into the national childhood vaccination schedule
1987: Mumps vaccination for babies at 15 months introduced into the national childhood vaccination schedule
2001: Hib vaccination introduced into the national childhood vaccination schedule and administered to all children in the first year of life
2001: HepB vaccination introduced into the national childhood vaccination schedule and administerd to all children in the 1st and 12th year of life
2007: IPV replaced OPV in the 1st year of life
2007: Acellular pertussis vaccine (aP) replaced the whole-cell vaccine (wP) in the 1st year of life
2010: Recommended PCV vaccination for babies in their 1st year of life introduced in the national vaccination schedule
2014: Updated recommendation for recommendation for vaccination against invasive meningococcal disease
2016: Pertussis vaccination during pregnancy introduced
2018: Change to the primary infant schedule from a 3+1 to 2+1 scheme in the first year of life



_______________________________________________________________________


VACCINATION FOR PREGNANT WOMEN
http://www.mzcr.cz/Verejne/dokumenty/doporuceni-narodni-imunizacni-komisenikopro-ockovani-tehotnych-zen-proti-per_11107_1985_5.html


_______________________________________________________________________


VACCINATIONS RECOMMENDED FOR AT-RISK GROUPS:
Healthcare workers: pertussis- recommended only - one booster dose should include pertussis (Td-acp); Hepatitis B - mandatory by law
Employees of Integrated Rescue System: Hepatitis A and B - mandatory by law
Military and judicial guard, social workers: Hepatitis B - mandatory by law
Laboratories working with virulent strains of rabies: Rabies - mandatory by law, revaccination after 2-5 years
Babies/children: pneumococcal disease for children at risk - mandatory by law; hepatitis B for children of HBsAg-positive mothers


_______________________________________________________________________


Date of last update: 26 September 2022